Frontiers in Oncology | Hematologic Malignancies

Brief Research Report

Published on 09 Dec 2020

Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures

in Hematologic Malignancies

Chuanyou Xia
Thale Kristin Olsen
A. Ali Zirakzadeh
Radwa Almamoun
Louise K. Sjöholm
Jenny Dahlström
Jan Sjöberg
Hans-Erik Claesson
John Inge Johnsen
Ola Winqvist

Frontiers in Oncology

doi 10.3389/fonc.2020.598872

3,043 views
2 citations

Systematic Review

Published on 09 Dec 2020

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics

in Hematologic Malignancies

Xavier Roussel
Etienne Daguindau
Ana Berceanu
Yohan Desbrosses
Walid Warda
Mathieu Neto da Rocha
Rim Trad
Eric Deconinck
Marina Deschamps
Christophe Ferrand

Frontiers in Oncology

doi 10.3389/fonc.2020.599933

22,098 views
18 citations

Correction

Published on 09 Dec 2020

Corrigendum: Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Qingqing Zheng
Chuang Jiang
Haiyan Liu
Wenge Hao
Pengfei Wang
Haiying Huang
Ziping Li
Jiabi Qian
Maoxiang Qian
Hui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.629875

1,109 views
2 citations

Review

Published on 09 Dec 2020

Role of Specific B-Cell Receptor Antigens in Lymphomagenesis

in Hematologic Malignancies

Lorenz Thurner
Sylvia Hartmann
Frank Neumann
Markus Hoth
Stephan Stilgenbauer
Ralf Küppers
Klaus-Dieter Preuss
Moritz Bewarder

Frontiers in Oncology

doi 10.3389/fonc.2020.604685

12,755 views
23 citations

Original Research

Published on 09 Dec 2020

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition

in Hematologic Malignancies

Kran Suknuntha
Yoon Jung Choi
Ho Sun Jung
Aditi Majumder
Sujal Shah
Igor Slukvin
Erik A. Ranheim

Frontiers in Oncology

doi 10.3389/fonc.2020.585151

4,324 views
4 citations

Original Research

Published on 03 Dec 2020

Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay

in Hematologic Malignancies

Timothy W. Farren
Kaushik S. Sadanand
Samir G. Agrawal

Frontiers in Oncology

doi 10.3389/fonc.2020.597730

3,906 views
9 citations

Review

Published on 02 Dec 2020

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas

in Hematologic Malignancies

Luciano Cascione
Luca Aresu
Michael Baudis
Francesco Bertoni

Frontiers in Oncology

doi 10.3389/fonc.2020.584095

9,578 views
16 citations

Original Research

Published on 30 Nov 2020

Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma

in Hematologic Malignancies

Joo Young Ha
Hyungwoo Cho
Heungsup Sung
Ah Ra Jung
Yoon Sei Lee
Sang-Wook Lee
Jin-Sook Ryu
Eun Jin Chae
Kyung Won Kim
Jooryung Huh

Frontiers in Oncology

doi 10.3389/fonc.2020.594692

4,809 views
13 citations

Systematic Review

Published on 26 Nov 2020

Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis

in Hematologic Malignancies

Fanqiao Meng
Xiuqiong Chen
Shunjie Yu
Xiaotong Ren
Zhaoyun Liu
Rong Fu
Lijuan Li

Frontiers in Oncology

doi 10.3389/fonc.2020.582686

11,503 views
18 citations

Review

Published on 26 Nov 2020

CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance

in Hematologic Malignancies

Giovanni D’Arena
Vincenzo De Feo
Giuseppe Pietrantuono
Elisa Seneca
Giovanna Mansueto
Oreste Villani
Francesco La Rocca
Fiorella D’Auria
Teodora Statuto
Luciana Valvano

Frontiers in Oncology

doi 10.3389/fonc.2020.584427

18,177 views
28 citations

Original Research

Published on 25 Nov 2020

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia

in Hematologic Malignancies

Jianai Sun
Yinjun Lou
Jingjing Zhu
Huafei Shen
De Zhou
Lixia Zhu
Xiudi Yang
Mixue Xie
Li Li
Xianbo Huang

Frontiers in Oncology

doi 10.3389/fonc.2020.577796

7,019 views
16 citations

Brief Research Report

Published on 20 Nov 2020

Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?

in Hematologic Malignancies

Marianna Mariani
Domenico Mattiucci
Elisa Rossi
Valeria Mari
Erico Masala
Angelica Giuliani
Valeria Santini
Fabiola Olivieri
Elena Marinelli Busilacchi
Stefania Mancini

Frontiers in Oncology

doi 10.3389/fonc.2020.595838

2,589 views
1 citation

Original Research

Published on 20 Nov 2020

Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients

in Hematologic Malignancies

Ruiqi Zhu
Huishan Tao
Wenyi Lin
Liang Tang
Yu Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.574939

6,276 views
29 citations

Original Research

Published on 20 Nov 2020

Cytotoxic T Cell Responses Induced by CS1/CRT Fusion DNA Vaccine in a Human Plasmacytoma Model

in Hematologic Malignancies

Xueshi Ye
Wanli Li
Jinwen Huang
Lifei Zhang
Ye Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.587237

3,133 views
2 citations

Case Report

Published on 19 Nov 2020

Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH/BCL3 Rearrangements: Report of Three Chinese Cases and Literature Review

in Hematologic Malignancies

Qinlu Li
Shugang Xing
Heng Zhang
Xia Mao
Min Xiao
Jia Wei
Ying Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.594732

5,812 views
3 citations

Original Research

Published on 19 Nov 2020

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways

in Hematologic Malignancies

Zhaoyun Liu
Chenhuan Xiang
Mei Han
Nanhao Meng
Jingyi Luo
Rong Fu

Frontiers in Oncology

doi 10.3389/fonc.2020.584530

5,395 views
17 citations

Mini Review

Published on 16 Nov 2020

The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia

in Hematologic Malignancies

Hong-Hu Zhu

Frontiers in Oncology

doi 10.3389/fonc.2020.592996

5,562 views
6 citations

Original Research

Published on 16 Nov 2020

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis

in Hematologic Malignancies

Maria Zingariello
Vittorio Rosti
Alessandro M. Vannucchi
Paola Guglielmelli
Maria Mazzarini
Giovanni Barosi
Maria Luisa Genova
Anna Rita Migliaccio

Frontiers in Oncology

doi 10.3389/fonc.2020.584541

4,928 views
11 citations

Original Research

Published on 12 Nov 2020

Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma

in Hematologic Malignancies

Moritz Bewarder
Maximilian Kiefer
Clara Moelle
Lisa Goerens
Stephan Stilgenbauer
Konstantinos Christofyllakis
Dominic Kaddu-Mulindwa
Natalie Fadle
Evi Regitz
Frank Neumann

Frontiers in Oncology

doi 10.3389/fonc.2020.580364

4,168 views
6 citations

Review

Published on 11 Nov 2020

Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art

in Hematologic Malignancies

Massimo Martino
Annalisa Paviglianiti
Mara Memoli
Giovanni Martinelli
Claudio Cerchione

Frontiers in Oncology

doi 10.3389/fonc.2020.592487

7,547 views
18 citations

Perspective

Published on 11 Nov 2020

UK Experience of an Alternative ATO Dosing Regimen in APL

in Hematologic Malignancies

Nigel Russell
Richard Dillon

Frontiers in Oncology

doi 10.3389/fonc.2020.594129

5,358 views
2 citations

Original Research

Published on 11 Nov 2020

Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Qingqing Zheng
Chuang Jiang
Haiyan Liu
Wenge Hao
Pengfei Wang
Haiying Huang
Ziping Li
Jiabi Qian
Maoxiang Qian
Hui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.579673

5,101 views
6 citations

Original Research

Published on 11 Nov 2020

RETRACTED: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis

in Hematologic Malignancies

Feifei Che
Jiao Chen
Chunqian Wan
Xiaobing Huang

Frontiers in Oncology

doi 10.3389/fonc.2020.571914

3,776 views
9 citations

Original Research

Published on 10 Nov 2020

Tissue Factor-Targeted “O2-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma

in Hematologic Malignancies

Ziying Li
Yanxue Yin
Weiwei Jin
Bo Zhang
Han Yan
Heng Mei
Huafang Wang
Tao Guo
Wei Shi
Yu Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.524712

4,383 views
10 citations